Literature DB >> 12610117

Vaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions.

Patricia Szajner1, Howard Jaffe, Andrea S Weisberg, Bernard Moss.   

Abstract

The vaccinia virus A30L protein is required for the association of electron-dense, granular, proteinaceous material with the concave surfaces of crescent membranes, an early step in viral morphogenesis. For the identification of additional proteins involved in this process, we used an antibody to the A30L protein, or to an epitope appended to its C terminus, to capture complexes from infected cells. A prominent 42-kDa protein was resolved and identified by mass spectrometry as the vaccinia virus G7L protein. This previously uncharacterized protein was expressed late in infection and was associated with immature virions and the cores of mature particles. In order to study the role of the G7L protein, a conditional lethal mutant was made by replacing the G7L gene with an inducible copy. Expression of G7L and formation of infectious virus was dependent on the addition of inducer. Under nonpermissive conditions, morphogenesis was blocked and viral crescent membranes and immature virions containing tubular elements were separated from the electron-dense granular viroplasm, which accumulated in large spherical masses. This phenotype was identical to that previously obtained with an inducible, conditional lethal A30L mutant. Additional in vivo and in vitro experiments provided evidence for the direct interaction of the A30L and G7L proteins and demonstrated that the stability of each one was dependent on its association with the other.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610117      PMCID: PMC149536          DOI: 10.1128/jvi.77.6.3418-3429.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  High-voltage electron microscope study of the release of vaccinia virus from whole cells.

Authors:  G V Stokes
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

Review 4.  Differences between extracellular and intracellular forms of poxvirus and their implications.

Authors:  E A Boulter; G Appleyard
Journal:  Prog Med Virol       Date:  1973

5.  An antigenic difference between intracellular and extracellular rabbitpox virus.

Authors:  G Appleyard; A J Hapel; E A Boulter
Journal:  J Gen Virol       Date:  1971-10       Impact factor: 3.891

6.  Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.

Authors:  W A Alexander; B Moss; T R Fuerst
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin.

Authors:  Y Zhang; B Moss
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

8.  Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.

Authors:  L G Payne
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

9.  Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes.

Authors:  J Tooze; M Hollinshead; B Reis; K Radsak; H Kern
Journal:  Eur J Cell Biol       Date:  1993-02       Impact factor: 4.492

10.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  33 in total

1.  Physical and functional interactions between vaccinia virus F10 protein kinase and virion assembly proteins A30 and G7.

Authors:  Patricia Szajner; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.

Authors:  Patricia Szajner; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis.

Authors:  Almira Punjabi; Paula Traktman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression.

Authors:  Susan Parrish; Bernard Moss
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture.

Authors:  Tatiana G Senkevich; Linda S Wyatt; Andrea S Weisberg; Eugene V Koonin; Bernard Moss
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

6.  Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum.

Authors:  Liliana Maruri-Avidal; Andrea S Weisberg; Himani Bisht; Bernard Moss
Journal:  J Virol       Date:  2012-11-28       Impact factor: 5.103

7.  Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Richard C Condit
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

Review 8.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

9.  Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Baron B D McFadden; Casey Paulasue Nielsen; Susan M D'Costa; Richard C Condit
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

10.  Functional characterization of the vaccinia virus I5 protein.

Authors:  Bethany Unger; R Jeremy Nichols; Eleni S Stanitsa; Paula Traktman
Journal:  Virol J       Date:  2008-12-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.